Iron is an essential nutrient that is regulated by several complex pathways within the body. Dysregulation of iron metabolism leads to common diseases such as hemochromatosis and anemia which affect several hundred million people worldwide. In the past 5 years, our understandings of the basic signaling mechanisms which regulate systemic iron homeostasis have begun to be illuminated. The master regulator of overall iron balance is hepcidin, a key hormone secreted by the liver in response to several stimuli including systemic iron levels. In the prior funding period, this grant supported our novel work demonstrating the central role of hemojuvelin (HJV) in the regulation of hepcidin. Our laboratory discovered that hemojuvelin is a BMP co-receptor whose BMP signaling ability is responsible for hepcidin regulation. Loss of HJV activity leads to the absence of hepcidin and iron overload (e.g. hemochromatosis), while excess BMP signaling leads to supraphysiologic levels of hepcidin and anemia. More recently, we have identified BMP6 as the key endogenous ligand for HJV. BMP6 binds directly to HJV protein and mice lacking BMP6 develop severe iron overload similar to HJV or hepcidin null mice. In addition, we have demonstrated that soluble HJV.Fc protein can effectively mobilize iron in mice by inhibition of endogenous BMP6 ligand. Thus, we have generated data that 1) HJV selectively binds BMP ligands, 2) HJV is required for hepcidin regulation, 3) HJV mutations in humans do not generate adequate BMP signals, 4) BMP6 is the endogenous ligand for HJV, 5) soluble HJV.Fc can mobilize iron in normal mice, and 6) the presence of HJV alters the ability of BMP ligands to utilize BMP type II receptors. In the next funding period, we propose to advance our investigations of the mechanisms of action of hemojuvelin by studying important unanswered questions regarding hemojuvelin biochemistry, cell biology, and in vivo physiology. Knowledge we gain from our studies may lead to new therapeutic strategies for the treatment of iron disorders.

Public Health Relevance

Iron is an essential nutrient whose regulation is tightly controlled by the body. This proposal will investigate how iron metabolism is controlled by the BMP co-receptor hemojuvelin. It is hoped that this work will lead to new treatment strategies for anemia and hemochromatosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK071837-07
Application #
8303251
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Wright, Daniel G
Project Start
2005-08-01
Project End
2015-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
7
Fiscal Year
2012
Total Cost
$378,813
Indirect Cost
$161,313
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred et al. (2016) On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med 22:945-51
Nai, Antonella; Rubio, Aude; Campanella, Alessandro et al. (2016) Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood 127:2327-36
Schaefer, Benedikt; Haschka, David; Finkenstedt, Armin et al. (2015) Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease. Hum Mol Genet 24:6254-63
Tesfay, Lia; Clausen, Kathryn A; Kim, Jin Woo et al. (2015) Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Res 75:2254-63
Meynard, Delphine; Babitt, Jodie L; Lin, Herbert Y (2014) The liver: conductor of systemic iron balance. Blood 123:168-76
Babitt, Jodie L; Lin, Herbert Y (2014) BuMPing iron with modified heparins. Blood 123:1440-1
Zhao, Yueshui; Xiao, Xiaoqiu; Frank, Stuart J et al. (2014) Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β. Am J Physiol Endocrinol Metab 307:E186-98
Sun, Chia Chi; Vaja, Valentina; Chen, Shanzhuo et al. (2013) A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transplant 28:1733-43
Liu, Wenjing; Li, Xiaoling; Zhao, Yueshui et al. (2013) Dragon (repulsive guidance molecule RGMb) inhibits E-cadherin expression and induces apoptosis in renal tubular epithelial cells. J Biol Chem 288:31528-39
Meynard, Delphine; Sun, Chia Chi; Wu, Qifang et al. (2013) Inflammation regulates TMPRSS6 expression via STAT5. PLoS One 8:e82127

Showing the most recent 10 out of 39 publications